|1.||Scheer, M: 1 article (03/2001)|
|2.||Staff, C: 1 article (03/2001)|
|3.||Kübler, A C: 1 article (03/2001)|
|4.||Zillmann, U: 1 article (03/2001)|
|5.||Haase, T: 1 article (03/2001)|
|6.||Benner, A: 1 article (03/2001)|
|7.||Flechtenmacher, C: 1 article (03/2001)|
|8.||Reuther, T: 1 article (03/2001)|
03/01/2001 - "[Clinical effectiveness of m-THPC-PEG in a new xenogenic animal tumor model for human squamous epithelial carcinomas]."
06/10/1998 - "Fluorescence microscopy studies showed that m-THPC-PEG was preferentially localized near the tumor vessels, whereas m-THPC was more diffusely distributed inside the tumor tissue. "
06/10/1998 - "The tumor to normal tissue ratios of radioactivity concentrations were always higher for m-THPC-PEG than for free m-THPC at any time point studied from 2 to 96 hr post-injection. "
06/10/1998 - "At different times after i.v. injection of both forms of 125I-labeled photosensitizer, m-THPC-PEG gave on average a 2-fold higher tumor uptake than free m-THPC. "
06/10/1998 - "To verify whether m-THPC-PEG conjugate remained phototoxic in vivo, PDT experiments were performed 72 hr after injection and showed that m-THPC-PEG was as potent as free m-THPC in the induction of tumor regression provided that the irradiation does for m-THPC-PEG conjugate was adapted to a well-tolerated 2-fold higher level. "
|2.||Polyethylene Glycols (Polyethylene Glycol)